admin_auro

January 6, 2018

Published by admin_auro at January 6, 2018

Categories

Molecular therapy for body weight control, energy homeostasis and TIIDM: Cilostazol, a drug used in the treatment of peripheral vascular disease, increases REV-ERB and its down stream target genes, inhibits lipid accumulation, improves dyslipidemia and insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM via up regulation of its target gene, 5/January/2018, 11.27 pm

Introduction: What they say A study from the Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, Florida 33458, USA shows that “Regulation of circadian behaviour […]

January 6, 2018

Published by admin_auro at January 6, 2018

Categories

Natural product-based therapy for Diabetic retinopathy: A pharmaceutical mixture encompassing t-AUCB, Epicatechin and Marine (t-AUCBEM) inhibits Soluble epoxide hydrolase (sEH) expression, decreases toxic 19,20-dihydroxydocosapentaenoic acid levels, inhibits pericyte loss, vascular permeability, and inflammation of the eye and progression of diabetic retinopathy, via down regulation of its target gene, 6/January/2018, 11.18 pm

Introduction: What they say A study from the Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany; and German Centre for […]

January 6, 2018

Published by admin_auro at January 6, 2018

Categories

Anti-infective Therapy: Nifedipine, an antihypertensive drug, inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, Influenza H1NI1, respiratory syncytial, Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 15, 6/January/2018, 11.05 pm

Introduction: What they say: A study from the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard Medical School, Charlestown, MA 02129, USA […]

January 6, 2018

Published by admin_auro at January 6, 2018

Categories

Molecular therapy for body weight control, energy homeostasis and TIIDM: Hydralazine, an anti-hypertensive drug, inhibits DNA methyltransferase 3a (Dnmt3a) expression, increases FGF21 expression, augments insulin sensitivity, increases glucose tolerance, and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 6/January/2017, 10.53 am

Introduction: What they say A study from Nutritional Sciences and Toxicology Department, University of California, Berkeley, Berkeley, United States shows that “Dnmt3a is an epigenetic mediator […]